Free Trial Information
BioCentury | Nov 25, 2020
Product Development

Nov. 25 Quick Takes: FDA approves Y-mAbs’ Danyelza; plus NIH’s ACTT-4; COVAXX, Urovant, SomaLogic, Eluminex and Liquidia

...participating were Farallon Capital Management, Foresite Capital, T. Rowe Price, Blue Water Life Science Advisors, Madryn Asset Management...
Read More
BioCentury | Jan 5, 2018
Financial News

Somalogic completes $200M funding round

...$200 million financing round on Jan. 4 led by iCarbonX. Nan Fung Life Sciences and Madryn Asset Management...
Read More
BioCentury | Jan 4, 2018
Financial News

SomaLogic completes $200M financing round

...completed a $200 million tranched financing round led by iCarbonX. Nan Fung Life Sciences and Madryn Asset Management...
Read More
Items per page:
1 - 3 of 3
BioCentury | Nov 25, 2020
Product Development

Nov. 25 Quick Takes: FDA approves Y-mAbs’ Danyelza; plus NIH’s ACTT-4; COVAXX, Urovant, SomaLogic, Eluminex and Liquidia

...participating were Farallon Capital Management, Foresite Capital, T. Rowe Price, Blue Water Life Science Advisors, Madryn Asset Management...
Read More
BioCentury | Jan 5, 2018
Financial News

Somalogic completes $200M funding round

...$200 million financing round on Jan. 4 led by iCarbonX. Nan Fung Life Sciences and Madryn Asset Management...
Read More
BioCentury | Jan 4, 2018
Financial News

SomaLogic completes $200M financing round

...completed a $200 million tranched financing round led by iCarbonX. Nan Fung Life Sciences and Madryn Asset Management...
Read More
Items per page:
1 - 3 of 3